1
Quintiles Overview
Quintiles applies the breadth and depth of our service offerings along with
extensive therapeutic, sc...
2
NDA Regulatory
Review
Biopharmaceutical Services
Companies
Payer and Provider
Commercial
Drug
Approval
Product Developme...
3
Programmatic Differentiation and
Outsourcing
All activities of bio-
pharma company
Core capabilities that
differentiate ...
4
Examples of Programmatic
Differentiation
• Expertise in disease
• Understanding of
mechanism of action of
drug
• Novel s...
5
Factors to Consider When Selecting
a Service-provider
• Bio-tech corporate strategy
> Anticipated duration of collaborat...
Upcoming SlideShare
Loading in …5
×

A Peek at CMO East 2013

364 views

Published on

Published in: Business, Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
364
On SlideShare
0
From Embeds
0
Number of Embeds
161
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

A Peek at CMO East 2013

  1. 1. 1 Quintiles Overview Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. • Quintiles is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 27,000 employees conducting business in more than 100 countries. • Quintiles has helped develop or commercialize 100% of 2012’s top 50 best selling products or compounds A fully integrated life cycle healthcare services provider Evaluate Pharma 2011 Report Top Selling Products, May 2, 2012; Quintiles internal project management databases.
  2. 2. 2 NDA Regulatory Review Biopharmaceutical Services Companies Payer and Provider Commercial Drug Approval Product Development Services Integrated Healthcare Services Biopharma Development Customers Biopharma Commercial & Other Customers Preclinical customers IND Regulatory Review
  3. 3. 3 Programmatic Differentiation and Outsourcing All activities of bio- pharma company Core capabilities that differentiate the company Activities that the company can efficiently develop internally Core capabilities that cannot be develop efficiently internally Capabilities that do not differentiate the company Programmatic approach to differentiation
  4. 4. 4 Examples of Programmatic Differentiation • Expertise in disease • Understanding of mechanism of action of drug • Novel study-design Differentiated- internally developed • Database of electronic medical records for planning and design capabilities (Infosario Design) • Biomarker development, industrialization and global dissemination (ADL) • Market-access commercial-clinical convergence Core but unable to develop efficiently • Global regulatory submission capability • Clinical operations activities (site initiation, monitoring, drug accountability) • Data management • PV reporting Non-core
  5. 5. 5 Factors to Consider When Selecting a Service-provider • Bio-tech corporate strategy > Anticipated duration of collaboration > Exit strategy • Bio-tech/service provider alignment > Therapeutic area alignment > Size-alignment > Country, regional and global alignment • Benchmarking- trust but verify • The service provider > Financial stability > Ethics and governance

×